Effect of Using a Dragon Design Nebulizer Mask on Treatment Duration, Compliance and Fear in Children
ConditionFear
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-6
SponsorKoç University
About this trial
Incorporating playful elements into medical devices has been shown to enhance the overall experience for pediatric patients. Children want a healthcare setting that is spacious, creative, imaginative, and contemporary. Additionally, a current retrospective study of 127,368 pediatric patients indicates that 71.26% of the visits involved children under five years old, and 23.64% of the cases were due to respiratory infections. This information highlights the prevalence of inhaler therapy in emergency departments, particularly among young children with respiratory issues. This study aims to evaluate the impact of using dragon/turtle-themed nebulizer masks on treatment application time, treatment adherence, and fear levels in children who present to emergency rooms. By addressing these environmental and procedural challenges, the study seeks to improve the overall experience and outcomes for pediatric patients undergoing inhaler therapy.
Eligibility criteria
Qualifiers
Aged between 3-6 years,
Presenting to the emergency department with a respiratory problem (such as an upper respiratory tract infection) requiring nebulizer treatment,
In general good health and suitable for nebulizer treatment (i.e., not having conditions like severe allergies or chronic respiratory failure),
Possessing age-appropriate language and communication skills,
Disqualifiers
Children with major medical or psychiatric comorbidities as reported by the physician, nurse, or parent,
Children with a chronic health condition requiring regular nebulizer use (such as asthma),
Children with a fever of 38°C (100.4°F) or higher,
Children who have started treatment with sedative or anticonvulsant medications,
Trial design
Treatments tested in this trial
- dragon themed nebulizer masks
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov